A groundbreaking HIV cure trial in Durban, South Africa shows hope: 20% of participants stayed off HIV meds for over 1.5 years, with their immune systems keeping the virus in check.
This first-of-its-kind African trial used combination immunotherapy—boosting the immune system after early HIV treatment.
Led by African scientists and focused on women, it proves advanced HIV research can thrive in resource-limited settings.
A major step forward in the global fight to end HIV.
SOURCE: Africa Health Research Institute
